Whilst the use of aspirin may demonstrate benefits for solid tumors or for those with hereditary cancer predisposition (i.e., Lynch syndrome), its efficacious role in ovarian cancer requires further exploration alongside targeted agents aimed at HIF-1α or improving tissue oxygenation [25]. Here, HIF1A is linked to Lynch syndrome.